These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8524760

  • 21. [Laser and chemotherapy and the immune status of patients with fibrous-cavernous tuberculosis].
    Sergeeva LV, Dobkin VG, Markov AN.
    Probl Tuberk; 1996; (1):22-4. PubMed ID: 8907479
    [Abstract] [Full Text] [Related]

  • 22. [Monitoring of chemotherapy in patients with pulmonary tuberculosis by the blood bacteriostatic activity-determining test].
    Manicheva OA, Skvortsova LA, Pavlova MV, Sapozhnikova NV, Archakova LI, Vishnevskiĭ BI.
    Probl Tuberk Bolezn Legk; 2008; (5):14-7. PubMed ID: 18711812
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Combined regular chemotherapy and lesion management under bronchofiberscope in proliferative endobronchial tuberculosis].
    Zheng DY, Zhou R, Chen P.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 30(4):492-3. PubMed ID: 16190411
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Efficiency of an intensive stage of chemotherapy for tuberculosis in elderly and senile patients].
    Karachunskiĭ MA, Uvarova TE.
    Probl Tuberk Bolezn Legk; 2004 Aug; (3):19-21. PubMed ID: 15338894
    [Abstract] [Full Text] [Related]

  • 29. [The use of microwave therapy in combined treatment of patients with pulmonary tuberculosis and chronic bronchitis].
    Petrenko VM, Korzhov VI, Gaĭovich AI, Sokirko TA, Mukhin AA.
    Probl Tuberk; 1991 Aug; (2):46-8. PubMed ID: 2034643
    [No Abstract] [Full Text] [Related]

  • 30. Aerosolized interferon-alpha treatment in patients with multi-drug-resistant pulmonary tuberculosis.
    Giosuè S, Casarini M, Ameglio F, Zangrilli P, Palla M, Altieri AM, Bisetti A.
    Eur Cytokine Netw; 2000 Mar; 11(1):99-104. PubMed ID: 10705306
    [Abstract] [Full Text] [Related]

  • 31. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group.
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Serological markers of pulmonary tuberculosis and of response to anti-tuberculosis treatment in a patient population in Guinea.
    Azzurri A, Kanaujia GV, Sow OY, Bah B, Diallo A, Del Prete G, Gennaro ML.
    Int J Immunopathol Pharmacol; 2006 Sep; 19(1):199-208. PubMed ID: 16569358
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.